Gordiantec is a start-up company and was founded on 25 August 2011. It is a private, unlisted Australian company. The company is funded by capital group Yuuwa Capital LP.
Gordiantec is developing applications of a technology implemented by personnel at the University of Western Australia / Western Australian Institute for Medical Research (WAIMR).
Gordiantec is validating algorithms for SNP data identification that are associated with disease outcomes and/or population sub-types. Gordiantec has filed or is filing patent applications for diagnostics in areas including diabetes and cancer. It is expanding application of its approach to new diseases.